To the EditorPostprandial relaxation of the proximal stomach, namely gastric accommodation, is a key mechanism for understanding symptom generation in functional dyspepsia [1]. Impaired gastric accommodation raises the postprandial intragastric pressure, thereby generating dyspeptic symptoms such as early satiety [1]. On the other hand, proton pump inhibitors (PPIs) are effective for relieving dyspeptic symptoms [1]. A human study has shown that rabeprazole, one of the newer drugs in the PPI class, increases production of nitric oxide, which mediates the relaxant response of the proximal stomach to a meal [2]. These observations suggest the possibility that PPIs enhance gastric accommodation. However, the possibility has not yet been addressed.Gastric accommodation is induced by duodenal exposure to nutrients or by gastric distension [3]. The nutrientinduced accommodation is studied using the gastric barostat by monitoring the incremental change in barostat volume after a caloric liquid meal, while keeping intragastric pressure constant. However, by this conventional barostat technique, the distension (pressure)-induced accommodation cannot be evaluated [4]. A recent study has shown that rapid gastric emptying (GE) of 1,000 ml of water can be a surrogate marker of impaired distensioninduced accommodation [5]: after aggressive gastric filling with 1,000 ml water, the resultant elevation in intragastric pressure determines GE, and therefore the higher luminal pressure due to the defective accommodation, accelerates GE [5]. In reverse, it is logical to consider that GE of 1,000 ml water is delayed when the distension-induced accommodation is enhanced. The aim of this preliminary study was to test our hypothesis that rabeprazole delays GE of 1,000 ml water. If the hypothesis is true, the enhancing effect of rabeprazole on distension-induced gastric accommodation will indirectly be supported.Nine, healthy, Helicobacter pylori-seronegative, male volunteers (30-39 years, 55-85 kg) were enrolled. All gave written informed consents and the study was approved by the Ethics Committee of Teikyo University. The [ 13 C]-acetate breath test was performed on two randomized occasions [6,7], which were at least 1 week apart. On one occasion, 20 mg of rabeprazole was orally administered for the preceding 2 days, and 1 h before the breath test on the third day. The last dose of rabeprazole was taken with 200 ml water. On the other occasion, the subjects received no pretreatment, but they drank 200 ml water 1 h before the test. On breath testing, 1,000 ml of mineral water containing 200 mg [ 13 C]-acetate was given at a rate of 200 ml/ min. Breath samples were collected at baseline and at 5-min intervals for 2 h. The half [ 13 CO 2 ] excretion time (t 1/2b ) and the time of the maximal [ 13 CO 2 ] (t lag ) were calculated [7]. Time course data of the [ 13 CO 2 ] excretion were analyzed using two-way repeated measures of analysis of variance, followed by a post hoc paired Student's t-test. Summary data (t 1/2b and t lag ) were analyze...